Clinical significance of 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography for the assessment of131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma
✍ Scribed by Azusa Nakazawa; Tetsuya Higuchi; Noboru Oriuchi; Yukiko Arisaka; Keigo Endo
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 231 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p
## Background: Positron emission tomography (pet) using (18)f-fluoro-2-deoxy-d-glucose (fdg) has been used for the evaluation of various tumors, but accumulation in inflammatory lesions makes it a controversial modality. the aim of this study was to investigate the usefulness of delayed scanning in
## Abstract ## BACKGROUND. The authors conducted a comprehensive review of the efficacy of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography (FDG‐PET) in the detection of primary tumors in patients with disseminated carcinoma of unknown primary site. ## METHODS. Ten studies (involvin